z-logo
Premium
A novel mediterranean “δβ‐thalassemia” determinant containing the δ + 27 and β°39 point mutations in cis
Author(s) -
Oggiano Lina,
Guiso Luciana,
Frogheri Laura,
Loudianos Georgios,
Pistidda Paola,
Rimini Elena,
Pirastu Mario,
Cao Antonio,
Longinotti Maurizio
Publication year - 1994
Publication title -
american journal of hematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.456
H-Index - 105
eISSN - 1096-8652
pISSN - 0361-8609
DOI - 10.1002/ajh.2830450113
Subject(s) - microcytosis , thalassemia , point mutation , genetics , allele , hemoglobinopathy , biology , microbiology and biotechnology , heterozygote advantage , gene , mutation , medicine , hemolytic anemia , immunology , anemia , iron deficiency
The term δβ‐thalassemia with normal HbF has been recently proposed to define heterogenous δ and β globin gene molecular defects involving the same chromosome in cis. Here, we describe a Sardinian family in which three members showing microcytosis, border‐line HbA 2 levels and normal HbF proved to be heterozygotes for δ + 27 and β°39 point mutations in cis by allele specific oligonucleotyde hybridization as well as by ECO 0 109 I endonuclease digestion and electrophoresis. As some of these β‐thalassemia carriers shows normal HbA 2 levels, knowledge of the molecular basis of this novel δβ‐thalassemia silent phenotype would be useful in thalassemia screening and genetic counselling. © 1994 Wiley‐Liss, Inc.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom